Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning

Christian A. Wysocki, Susan B. Burkett, Angela Panoskaltsis-Mortari, Suzanne L. Kirby, Andrew D. Luster, Karen McKinnon, Bruce R. Blazar, Jonathan S. Serody

Research output: Contribution to journalArticle

99 Citations (Scopus)

Abstract

The coordinated expression of chemokines and receptors may be important in the directed migration of alloreactive T cells during graft-vs-host disease (GVHD). Recent work demonstrated in a murine model that transfer of CCR5-deficient (CCR5-/-) donor cells to nonconditioned haploidentical recipients resulted in reduced donor cell infiltration in liver and lymphoid tissues compared with transfer of CCR5-/- cells. To investigate the function of CCR5 during GVHD in conditioned transplant recipients, we transferred CCR5-/- or wild-type C57BL/6 (B6) T cells to lethally irradiated B6D2 recipients. Unexpectedly, we found an earlier time to onset and a worsening of GVHD using CCR5-/- T cells, which was associated with significant increases in the accumulation of alloreactive CD4+ and CD8+ T cells in liver and lung. Conversely, the transfer of CCR5 -/- donor cells to nonirradiated recipients led to reduced infiltration of target organs, confirming previous studies and demonstrating that the role of CCR5 on donor T cells is dependent on conditioning of recipients. Expression of proinflammatory chemokines in target tissues was dependent on conditioning of recipients, such that CXCL10 and CXCL11 were most highly expressed in tissues of irradiated recipients during the first week post-transplant. CCR5-/- T cells were shown to have enhanced migration to CXCL10, and blocking this ligand in vivo improved survival in irradiated receiving recipients receiving CCR5-/- T cells. Our data indicate that the effects of inhibiting CCR5/ligand interaction on donor T cells during GVHD differ depending on conditioning of recipients, a finding with potentially important clinical significance.

Original languageEnglish (US)
Pages (from-to)845-854
Number of pages10
JournalJournal of Immunology
Volume173
Issue number2
StatePublished - Jul 15 2004

Fingerprint

Graft vs Host Disease
Tissue Donors
T-Lymphocytes
Ligands
Chemokine Receptors
Liver
Lymphoid Tissue
Chemokines
Transplants
Lung
Survival

ASJC Scopus subject areas

  • Immunology

Cite this

Wysocki, C. A., Burkett, S. B., Panoskaltsis-Mortari, A., Kirby, S. L., Luster, A. D., McKinnon, K., ... Serody, J. S. (2004). Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning. Journal of Immunology, 173(2), 845-854.

Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning. / Wysocki, Christian A.; Burkett, Susan B.; Panoskaltsis-Mortari, Angela; Kirby, Suzanne L.; Luster, Andrew D.; McKinnon, Karen; Blazar, Bruce R.; Serody, Jonathan S.

In: Journal of Immunology, Vol. 173, No. 2, 15.07.2004, p. 845-854.

Research output: Contribution to journalArticle

Wysocki, CA, Burkett, SB, Panoskaltsis-Mortari, A, Kirby, SL, Luster, AD, McKinnon, K, Blazar, BR & Serody, JS 2004, 'Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning', Journal of Immunology, vol. 173, no. 2, pp. 845-854.
Wysocki CA, Burkett SB, Panoskaltsis-Mortari A, Kirby SL, Luster AD, McKinnon K et al. Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning. Journal of Immunology. 2004 Jul 15;173(2):845-854.
Wysocki, Christian A. ; Burkett, Susan B. ; Panoskaltsis-Mortari, Angela ; Kirby, Suzanne L. ; Luster, Andrew D. ; McKinnon, Karen ; Blazar, Bruce R. ; Serody, Jonathan S. / Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning. In: Journal of Immunology. 2004 ; Vol. 173, No. 2. pp. 845-854.
@article{4bcb51471cc64bee8fc98ef4f57218f6,
title = "Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning",
abstract = "The coordinated expression of chemokines and receptors may be important in the directed migration of alloreactive T cells during graft-vs-host disease (GVHD). Recent work demonstrated in a murine model that transfer of CCR5-deficient (CCR5-/-) donor cells to nonconditioned haploidentical recipients resulted in reduced donor cell infiltration in liver and lymphoid tissues compared with transfer of CCR5-/- cells. To investigate the function of CCR5 during GVHD in conditioned transplant recipients, we transferred CCR5-/- or wild-type C57BL/6 (B6) T cells to lethally irradiated B6D2 recipients. Unexpectedly, we found an earlier time to onset and a worsening of GVHD using CCR5-/- T cells, which was associated with significant increases in the accumulation of alloreactive CD4+ and CD8+ T cells in liver and lung. Conversely, the transfer of CCR5 -/- donor cells to nonirradiated recipients led to reduced infiltration of target organs, confirming previous studies and demonstrating that the role of CCR5 on donor T cells is dependent on conditioning of recipients. Expression of proinflammatory chemokines in target tissues was dependent on conditioning of recipients, such that CXCL10 and CXCL11 were most highly expressed in tissues of irradiated recipients during the first week post-transplant. CCR5-/- T cells were shown to have enhanced migration to CXCL10, and blocking this ligand in vivo improved survival in irradiated receiving recipients receiving CCR5-/- T cells. Our data indicate that the effects of inhibiting CCR5/ligand interaction on donor T cells during GVHD differ depending on conditioning of recipients, a finding with potentially important clinical significance.",
author = "Wysocki, {Christian A.} and Burkett, {Susan B.} and Angela Panoskaltsis-Mortari and Kirby, {Suzanne L.} and Luster, {Andrew D.} and Karen McKinnon and Blazar, {Bruce R.} and Serody, {Jonathan S.}",
year = "2004",
month = "7",
day = "15",
language = "English (US)",
volume = "173",
pages = "845--854",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "2",

}

TY - JOUR

T1 - Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning

AU - Wysocki, Christian A.

AU - Burkett, Susan B.

AU - Panoskaltsis-Mortari, Angela

AU - Kirby, Suzanne L.

AU - Luster, Andrew D.

AU - McKinnon, Karen

AU - Blazar, Bruce R.

AU - Serody, Jonathan S.

PY - 2004/7/15

Y1 - 2004/7/15

N2 - The coordinated expression of chemokines and receptors may be important in the directed migration of alloreactive T cells during graft-vs-host disease (GVHD). Recent work demonstrated in a murine model that transfer of CCR5-deficient (CCR5-/-) donor cells to nonconditioned haploidentical recipients resulted in reduced donor cell infiltration in liver and lymphoid tissues compared with transfer of CCR5-/- cells. To investigate the function of CCR5 during GVHD in conditioned transplant recipients, we transferred CCR5-/- or wild-type C57BL/6 (B6) T cells to lethally irradiated B6D2 recipients. Unexpectedly, we found an earlier time to onset and a worsening of GVHD using CCR5-/- T cells, which was associated with significant increases in the accumulation of alloreactive CD4+ and CD8+ T cells in liver and lung. Conversely, the transfer of CCR5 -/- donor cells to nonirradiated recipients led to reduced infiltration of target organs, confirming previous studies and demonstrating that the role of CCR5 on donor T cells is dependent on conditioning of recipients. Expression of proinflammatory chemokines in target tissues was dependent on conditioning of recipients, such that CXCL10 and CXCL11 were most highly expressed in tissues of irradiated recipients during the first week post-transplant. CCR5-/- T cells were shown to have enhanced migration to CXCL10, and blocking this ligand in vivo improved survival in irradiated receiving recipients receiving CCR5-/- T cells. Our data indicate that the effects of inhibiting CCR5/ligand interaction on donor T cells during GVHD differ depending on conditioning of recipients, a finding with potentially important clinical significance.

AB - The coordinated expression of chemokines and receptors may be important in the directed migration of alloreactive T cells during graft-vs-host disease (GVHD). Recent work demonstrated in a murine model that transfer of CCR5-deficient (CCR5-/-) donor cells to nonconditioned haploidentical recipients resulted in reduced donor cell infiltration in liver and lymphoid tissues compared with transfer of CCR5-/- cells. To investigate the function of CCR5 during GVHD in conditioned transplant recipients, we transferred CCR5-/- or wild-type C57BL/6 (B6) T cells to lethally irradiated B6D2 recipients. Unexpectedly, we found an earlier time to onset and a worsening of GVHD using CCR5-/- T cells, which was associated with significant increases in the accumulation of alloreactive CD4+ and CD8+ T cells in liver and lung. Conversely, the transfer of CCR5 -/- donor cells to nonirradiated recipients led to reduced infiltration of target organs, confirming previous studies and demonstrating that the role of CCR5 on donor T cells is dependent on conditioning of recipients. Expression of proinflammatory chemokines in target tissues was dependent on conditioning of recipients, such that CXCL10 and CXCL11 were most highly expressed in tissues of irradiated recipients during the first week post-transplant. CCR5-/- T cells were shown to have enhanced migration to CXCL10, and blocking this ligand in vivo improved survival in irradiated receiving recipients receiving CCR5-/- T cells. Our data indicate that the effects of inhibiting CCR5/ligand interaction on donor T cells during GVHD differ depending on conditioning of recipients, a finding with potentially important clinical significance.

UR - http://www.scopus.com/inward/record.url?scp=3142661927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3142661927&partnerID=8YFLogxK

M3 - Article

C2 - 15240671

AN - SCOPUS:3142661927

VL - 173

SP - 845

EP - 854

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 2

ER -